Morphology of experimental diabetes and cerebral ischemia in the rat brain

Folia Neuropathologica

Volumn 37, Issue 4, 1999, Pages 252-255

  Piotrowski, Piotr ^a  

^a MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

Cerebral ischemia; Diabetes; Encephalopathy; Streptozotocin

Indexed keywords

STREPTOZOCIN;

AMYGDALOID NUCLEUS; ANIMAL; ARTICLE; BRAIN; BRAIN CORTEX; BRAIN ISCHEMIA; EXPERIMENTAL DIABETES MELLITUS; MALE; PATHOLOGY; RAT;

AMYGDALA; ANIMALS; BRAIN; BRAIN ISCHEMIA; CEREBRAL CORTEX; DIABETES MELLITUS, EXPERIMENTAL; MALE; RATS; STREPTOZOCIN;

EID: 0033253448     PISSN: 00283894     EISSN: 1509572X     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Affolter V, Boujon P, Bestetti G, Rossi GL: Hypothalamic and cortical neurons of normotensive and spontaneously hypertensive rats are differently affected by streptozotocin diabetes. Acta Neuropathol (Berl.), 1986, 70, 135-141.
2. Bestetti G, Rossi GL: Hypothalamic lesions in rats with long-term streptozotocin -induced diabetes mellitus. A semiquantitative, light and electron microscopic study. Acta Neuropathol (Berl), 1980, 52, 119-127.
3. Bestetti G, Hofer R, Rossi GL: The preoptic-suprachiasmatic nuclei though morphologically heterogenous are equally affected by streptozotocin diabetes. Exp Brain Res, 1987, 66, 74-82.
4. Biessels G and Gispen WH: The calcium hypothesis of brain aging and neurodegenerative disorders: significance in diabetic neuropathy. Life Sci, 1996, 59(5/6), 379-387.
5. Biessels GJ, Kappelle AC, Bravenboer B, Erkelens DW, Gispen WH: Cerebral function in diabetes mellitus. Diabetologia, 1994, 37, 643-650.
6. Giffard RG, Monyer H, Choi DW: Selective vulnerability of cultured cortical glia to injury by extracellular acidosis. Brain Res, 1990, 530, 138-41.
7. Hatcher HC, Ma JX, Chao J, Chao L, Ottlecz A: Kallikrein-binding levels are reduced in the retinas of streptozotocin-induced diabetic rats. Invest Ophtalmol Vis Sci, 1997, 38(3), 658-664.
8. King GL, Brownlee M: The cellular and molecular mechanisms of diabetic complications. Endocrinol Metab Clin North Am, 1996 Jun, 25, 255-270.
9. Lanier WL, Hofer RE, Gallagher WJ: Metabolism of glucose, glycogen and high-energy phosphates during transient forebrain ischemia in diabetic rats: effect of insulin treatment. Anesthesiology, 1996, 84(4), 917-25.
10. Li C, Li PA, He QP, Ouyang YB, Siesjo BK: Effects of streptozotocin-induced hyperglycemia on brain damage following transient ischemia. Neurobiol Dis, 1998, 5(2), 117-128.
11. Mordes JP and Rossini AA: Animal models of diabetes. Am J Med., 1981, 70, 353-360.
12. Mukai N, Hori S, Pomeroy M: Cerebral lesions in rats with streptozotocin-induced diabetes. Acta Neuropathol (Berl), 1980, 51, 79-84.
13. Paolisso G, Giugliano D, Pizza G et al.: Glutathione infusion potentiates glucose-induced insulin secretion in aged patients with impaired glucose tolerance. Diabetes Care, 1992, 15, 1-7.
14. Takahashi K, Ghatei MA, Lam H-C, O'Halloran DJ, Bloom SR: Elevated plasma endothelin in patients with diabetes mellitus. Diabetologia, 1990, 33, 306-310.
15. Takehara K, Tashima K, Takeuchi K: Alterations in duodenal bicarbonate secretion and mucosal secretion and mucosal susceptibility to acid in diabetic rats. Gastroenterology, 1997, 112(2), 418-428.